Skip to main content
Clinical Trials/EUCTR2013-001147-31-DK
EUCTR2013-001147-31-DK
Active, not recruiting
Not Applicable

Aortic Valve Stenosis and Myocardial Efficiency – a Prognostic Marker and a Target for Intervention? - MELVAS

Aarhus University Hospital, Department of Cardiology0 sitesJune 6, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic stenosis
Sponsor
Aarhus University Hospital, Department of Cardiology
Status
Active, not recruiting
Last Updated
10 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 6, 2013
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Aarhus University Hospital, Department of Cardiology

Eligibility Criteria

Inclusion Criteria

  • \- Aortic valve area \<1,2 cm2 and/or transaortic maximal velocity (VmaxAO) of 3,0\-5,0 m/s
  • \- Sinus rhythm \>60/min after 5 minutes rest
  • \- LVEF \>55%
  • \- Male or female
  • \- Age 20\-100 years old
  • \- Safe birth control management (intrauterine devices or hormonal contraceptives (contraceptive pills, implants, transdermal patches, hormonal vaginal devices or injections with prolonged release))
  • \- Negative urine\-HCG for women of childbearing potential
  • \- Ability to understand the written patient information and to give informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:

Exclusion Criteria

  • \- Systolic BP \<100 mmHg after 5 minutes of rest
  • \- Left ventricular posterior wall thickness \>17 mm
  • \- Signs or history of myocardial infarction and/or severe ischemic heart disease
  • \- Severe asthma or chronic obstructive pulmonary disease
  • \- New York Heart Association (NYHA) classification \> I due to AS
  • \- NYHA \> II due to non\-cardiac causes
  • \- 2? or 3? atrioventricular block
  • \- Ongoing beta\-blocker therapy
  • \- Ongoing verapamil or diltiazem therapy
  • \- Ongoing monoamine oxidase inhibitors therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials